Posts tagged geneva

Historic Opportunity to Tackle Drug-Resistant Tuberculosis at Risk
People Living with MDR-TB and Health Care Providers Call for Urgent Action

Two new drugs effective against multidrug-resistant tuberculosis (MDR-TB) must be introduced to improve treatment regimens in countries with a high burden of the devastating disease, a group of people living with MDR-TB and the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) announced in a public manifesto issued today.

Photo: A child at MSF’s intensive feeding center in Guidam Roumdji, Maradi region. Niger 2011 © Alessandra Vilas Boas
Rotavirus Research Results Show Need to Tailor Vaccines to Improve Their Impact
Cape Town/Geneva/New York, November 8, 2012- Research presented today by Epicentre, the epidemiological research arm of MSF and other African researchers, contributes to the growing body of evidence that the two existing rotavirus vaccines may not be best adapted for use in Africa.
“Vaccine developers have not taken into account the full rotavirus picture in places that are hardest hit by diarrheal illness and deaths caused by rotavirus,” said Dr. Anne-Laure Page, an epidemiologist at Epicentre. “This study adds to the growing body of research that underscores the need to ensure that vaccines are developed that effectively address the needs of developing countries.”
The two available rotavirus vaccines were developed and tested in industrialized countries, and have an efficacy rate of 90 percent against severe diarrhea in these countries, compared to an estimated 50-60 percent in countries in Africa and Asia. The current vaccines are also bulky and have a limited shelf life at room temperature, further making them unsuitable for developing countries that lack adequate refrigeration capacity.
“The fact that currently available vaccines are not easy to use in the places that are hardest to reach contributes to the fact that 22 million children born each year do not receive even the basic vaccination package,” said Elder.

Photo: A child at MSF’s intensive feeding center in Guidam Roumdji, Maradi region. Niger 2011 © Alessandra Vilas Boas

Rotavirus Research Results Show Need to Tailor Vaccines to Improve Their Impact

Cape Town/Geneva/New York, November 8, 2012- Research presented today by Epicentre, the epidemiological research arm of MSF and other African researchers, contributes to the growing body of evidence that the two existing rotavirus vaccines may not be best adapted for use in Africa.

“Vaccine developers have not taken into account the full rotavirus picture in places that are hardest hit by diarrheal illness and deaths caused by rotavirus,” said Dr. Anne-Laure Page, an epidemiologist at Epicentre. “This study adds to the growing body of research that underscores the need to ensure that vaccines are developed that effectively address the needs of developing countries.”

The two available rotavirus vaccines were developed and tested in industrialized countries, and have an efficacy rate of 90 percent against severe diarrhea in these countries, compared to an estimated 50-60 percent in countries in Africa and Asia. The current vaccines are also bulky and have a limited shelf life at room temperature, further making them unsuitable for developing countries that lack adequate refrigeration capacity.

“The fact that currently available vaccines are not easy to use in the places that are hardest to reach contributes to the fact that 22 million children born each year do not receive even the basic vaccination package,” said Elder.

Photo: Somali refugees in Dadaab arrive in Ifo 2 camp after being moved by officials from the outskirts of Dagahaley camp. Kenya 2011 © Lynsey Addario/VII

Dadaab: Leaders Must Not Fail Refugees in the World’s Largest Camp

In Geneva, world leaders commenced this week for the annual meeting of the executive committee of the United Nations High Commissioner for Refugees (UNHCR). Issues on refugee rights and safety were discussed, as MSF brought attention to the half a million Somalis living in extreme conditions and under fear in camps in Kenya. Urgent steps must also be taken to meet the basic needs of the refugees, particularly shelter and sanitation. 

“We are seriously questioning the overall level of assistance provided to the refugees,” said Bruno Jochum, MSF general director, who visited Dadaab’s Dagahaley camp last week. “With security conditions worsening, basic services and the provision of aid have been significantly reduced, so it is no surprise that refugees are yet again facing disease outbreaks.”

Photo: Somali refugees in Dadaab arrive in Ifo 2 camp after being moved by officials from the outskirts of Dagahaley camp. Kenya 2011 © Lynsey Addario/VII

Dadaab: Leaders Must Not Fail Refugees in the World’s Largest Camp

In Geneva, world leaders commenced this week for the annual meeting of the executive committee of the United Nations High Commissioner for Refugees (UNHCR). Issues on refugee rights and safety were discussed, as MSF brought attention to the half a million Somalis living in extreme conditions and under fear in camps in Kenya. Urgent steps must also be taken to meet the basic needs of the refugees, particularly shelter and sanitation.

“We are seriously questioning the overall level of assistance provided to the refugees,” said Bruno Jochum, MSF general director, who visited Dadaab’s Dagahaley camp last week. “With security conditions worsening, basic services and the provision of aid have been significantly reduced, so it is no surprise that refugees are yet again facing disease outbreaks.”

STOP NOVARTIS: Flashmob in Geneva from MSF Access Campaign on Vimeo.

STOP NOVARTIS: Flashmob in Geneva

Last Wednesday, 200+ people froze in the streets of Geneva to protest the attack on generic medicines by Swiss pharmaceutical company Novartis. Watch to see how passerbys reacted and to hear MSF & others chant, “LIVES BEFORE PROFITS”.